Renal uptake of an 18-mer phosphorothioate oligonucleotide
Open Access
- 1 October 1995
- journal article
- Published by Elsevier in Kidney International
- Vol. 48 (4) , 1226-1232
- https://doi.org/10.1038/ki.1995.406
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cellular Uptake of Oligodeoxynucleotide Phosphorothioates and Their AnalogsAntisense Research and Development, 1994
- Gene-Mimetic Substances: Drugs Designed to Intervene in Gene ExpressionPublished by Elsevier ,1994
- Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.Proceedings of the National Academy of Sciences, 1993
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Current concepts in antisense drug designJournal of Medicinal Chemistry, 1993
- Progress toward oligonucleotide therapeutics: pharmacodynamic propertiesThe FASEB Journal, 1993
- Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activityNucleic Acids Research, 1992
- Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.Proceedings of the National Academy of Sciences, 1991
- Progressive glomerular injury after limited renal infarction in the ratAmerican Journal of Physiology-Renal Physiology, 1988
- Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2Nature, 1987